Rights and Permissions
Bollinger RM, Keleman A, Thompson R, et alFalls: a marker of preclinical Alzheimer disease: a cohort study protocolBMJ Open 2021;11:e050820. doi: 10.1136/bmjopen-2021-050820
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
This article was published in BMJ Open following peer review and can also be viewed on the journal’s website at http://bmjopen.bmj.com.
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Bollinger, Rebecca M; Keleman, Audrey; Thompson, Regina; Westerhaus, Elizabeth; Fagan, Anne M; Benzinger, Tammie Ls; Schindler, Suzanne E; Xiong, Chengjie; Balota, David; Morris, John C; Ances, Beau M; and Stark, Susan L, ,"Falls: A marker of preclinical Alzheimer disease: A cohort study protocol." BMJ Open.,. . (2021).